2017 was a big year for FDA digital health regulations

In a recent article, HealthcareITnews reviews the important steps taken by the FDA last year toward regulating decision support, software-as-a-medical-device, mobile tech in clinical trials and more.

Beyond fielding an ever-increasing number of digital health clearances, the FDA had a full plate in 2017 as it sought to revise its regulatory processes for the shifting healthcare landscape. The beginning of the year saw a new administration take the reins, and with it the nomination and appointment of a new commissioner, Scott Gottlieb.

By year's end, the new guard already had announced and implemented a firm-focused pre-certification program, released new guidances addressing provisions of 2016's 21st Century Cures Act, and outlined a handful of other ongoing initiatives that are sure to impact the digital health industry. The article describes a rundown of the agency's actions and announcements during 2017....

Read the full article


Date: 15/01/2018 | Tag: | News: 724 of 826
All news

News

More news

Events

More events
newsletter

Subscribe to the VPH Institute Newsletter

Accept Privacy Policy

ARCHIVE

Read all the newsletters of the VPH Institute

GO